In the lead-up to the capture of Venezuelan President Nicolás Maduro, there was a sharp unwinding of short positions in the U.S. Oil and Gas Drilling sector, as evidenced by EquiLend’s premier Data & Analytics platform.

EquiLend’s data, reported in real time, revealed iRobot’s borrow costs spiked 4,700% this month, but traditional short-interest reports won’t show that for weeks.

Borrow demand in Blue Owl Capital’s listed vehicles (OWL US and OBDC US) has surged in recent months, indicating an early signal of concerns around the private credit market. EquiLend’s Borrow Quantity, a leading indicator of short interest, for OWL US has jumped 150% since September, rising from 33.4 million to 83.5 million shares, while OBDC US has climbed to 16.4 million shares from 10.2 million over the same period. EquiLend’s real-time securities lending data suggests investors are positioning for further declines in OWL US beyond its 25% slide since September.

Last week, Motorsport Games Inc. (MSGM) reported a strong Q3 2025, with revenue up 72% year-on-year and a return to profitability on the back of the Le Mans Ultimate game over the summer. Yet the rally quickly met skepticism. Investors are uneasy about the company’s dependence on one blockbuster title, a lack of forward guidance, and a $1 million decline in NASCAR revenue following the loss of image rights earlier this year.

Luminar Technologies (LAZR US) investors received a trick and not a treat this Halloween.

The retail investing community is at it again as Beyond Meat (BYND US) is the latest meme stock to hit the news.

In an unforeseen move, S&P Global Ratings downgraded the French sovereign credit score from AA- to A+ amidst recent political turmoil in Paris.

After an 80% rally year-to-date, Applovin (APP US) fell 14% on October 6 following S&P 500 inclusion and reports of an SEC probe into its data-collection policies.

The warning signs were there, EquiLend’s Borrow Quantity surged +1,300% between Sept 18–22, rising from 1.4M to 19.35M shares, a clear indication that short sellers were positioning ahead of the selloff.

Tilray Brands (TLRY US), a cannabis wellness company best known for its infused beverages and foods, has long been a volatile stock. That volatility hit overdrive this week after President Trump posted a Sunday video touting cannabidiol’s potential benefits for seniors. Cannabis stocks roared higher Monday. Tilray led the charge, soaring 61% by the close. 

A 2020 IPO via SPAC focused on purchasing US-based real estate directly from homeowners, Opendoor Technologies (OPEN US), checked all the short-selling buzzwords over the past two months as retail investors boosted shares by over 1700%.

Foot Locker’s $2.4B merger with DICK’S Sporting Goods closes September 8 – and our data shows the arbitrage pressure building.

Borrow balances more than doubled in two weeks, while fees spiked above 14,000 bps before sliding back near 900. Is this stabilization — or just the calm before another storm?

Only EquiLend’s securities lending data reveals the full picture.

Cracker Barrel encountered recent challenges when the company faced swift and significant public backlash in August 2025 after unveiling a new, modernized logo. The simplified design was met with widespread criticism from customers, who viewed the change as a departure from the brand’s traditional, nostalgic image. In response to the latest news, we observed a rise in short interest, as EquiLend Borrow Quantity had increased by more than 1 million since mid-August and currently stands above 4.6 million shares. Social media amplified the negative sentiment, and the company’s stock price continued to decline.

EquiLend Data & Analytics presents a comparative analysis revealing critical lockup dynamics in securities lending markets. CoreWeave (CRWV) demonstrated extreme volatility around its accelerated lockup expiration on August 14, 2025, with borrowing costs peaking at 44,324 bps before collapsing. CRCL exhibits similar pre-lockup warning signals with utilization remaining elevated, suggesting potential for comparable volatility. Daily monitoring of borrowing metrics is essential to stay ahead of lockup-driven supply shocks.

In this EquiLend Data & Analytics Market Flash, we provide a concluding analysis of the significant build-up of short interest in Paramount Global (PARA).

In our latest EquiLend Data & Analytics Market Flash, we analyze the multi-month build-up of short interest in Baxter International Inc. (BAX).

A key theme emerging in the market year-to-date is the notable underperformance of consensus bearish trades.

Insight JULY 25, 2025 Market Flash Market Flash on Kohl’s (KSS) and Opendoor (OPEN) The Return of Meme Stock Mania Recent market activity has shown how heavily shorted stocks can be affected by coordinated retail trading campaigns. Our analysis of Kohl’s Corporation (KSS) and Opendoor Technologies (OPEN) identifies patterns in securities finance metrics that indicate […]

Lucid Motors price soared nearly 40% following its robotaxi deal with Uber, but are the shorts positioning for a fall?

EquiLend’s data for Unusual Machines (UMAC) signaled investor skepticism ahead of a recent price drop.

As the price of Cyngn Inc. (CYN) rallied 120% in recent weeks following news of its partnership with Nvidia, EquiLend Data & Analytics identified increasing short positions.

EquiLend Data & Analytics surfaced elevated short interest in NOVA, averaging 28.8%, well before the June 9 bankruptcy filing.

This Hong Kong-listed pharmaceutical stock climbed 30% in 3 weeks — yet short positioning rose sharply: borrow quantity increased 182% and utilization more than doubled.

UnitedHealth Group (TICKER: UNH) shares fell from $600 on April 11 to $275 as of May 15 erasing over $300 billion in market value as rising medical costs, regulatory pressures and a Department of Justice criminal investigation into possible Medicare fraud undermined investor confidence.

EquiLend Data & Analytics identifies NetClass Technology as a prime short squeeze candidate, with its short squeeze score at 90.

EquiLend Data & Analytics identifies Regencell Bioscience as a prime short squeeze candidate, with its short squeeze score at 88.

EquiLend Data & Analytics identifies Janover Inc as a prime short squeeze candidate, as the EquiLend Short Squeeze Score surged to 86 indicating extreme potential for continued short covering.

EquiLend Data & Analytics identifies Summit Therapeutics as a prime short squeeze candidate, with its squeeze score surging 43.0 points to 66 in just one month. With utilization approaching 78.98% and elevated borrow fees, short sellers are facing mounting pressure as positive clinical trial results drive momentum.